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Abstract
Background: This abandoned randomised controlled trial assessed the effects of hospitalisation
from 24 to 30 weeks gestation for women with a triplet pregnancy on the risk of preterm birth.
Methods:  Women with a triplet pregnancy and no other condition necessitating hospital
admission were approached for participation in the study, and randomised to either antenatal
hospitalisation (hospitalised group), or to routine antenatal care (control group). The
randomisation schedule used variable blocks with stratification by parity, and a researcher not
involved with clinical care contacted by telephone to determine treatment allocation by opening
the next in a series of consecutively numbered, opaque, sealed envelopes. Primary study outcomes
were preterm birth (defined as birth less than 37 weeks gestation) and very preterm birth (defined
as birth less than 34 weeks gestation), and the development of maternal pregnancy induced
hypertension. The trial was ceased prior to achieving the calculated sample size due to difficulties
in recruitment. The results of this randomised controlled trial were then combined with the results
of another comparing bed rest in women with a triplet pregnancy.
Results: Seven women with a triplet pregnancy were recruited to the trial, with three randomised
to the hospitalisation group, and four to the control group. There were no statistically significant
differences between the two groups for the primary outcomes birth before 37 weeks (3/3
hospitalisation group versus 4/4 control group; relative risk (RR) not estimable), birth before 34
weeks (3/3 hospitalisation group versus 2/4 control group; RR 2.00 95% Confidence Intervals (CI)
0.75–5.33) and pregnancy induced hypertension (1/3 hospitalisation group versus 1/4 control
group; RR 1.33 95%CI 0.13–13.74).
When the results of this trial were incorporated into a meta-analysis with the previous randomised
controlled trial assessing hospitalisation and bed rest for women with a triplet pregnancy, (total
sample size 26 women and 78 infants), there were no statistically significant differences identified
between the two groups.
Conclusion: The results of this trial and meta-analysis suggest no benefit of routine hospitalisation
and bed rest for women with a triplet pregnancy to reduce the risk of preterm birth. The adoption
or continuation of a policy of routine hospitalisation and bed rest for women with an
uncomplicated triplet pregnancy cannot be recommended.
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Background
Women and infants of a multiple pregnancy are recog-
nised to be at increased risk of adverse outcome when
compared with singletons. The greatest risk to infants of a
multiple pregnancy is being born preterm, with preterm
birth, defined as birth less than 37 weeks gestation, and
very preterm birth less than 32 weeks gestation. The pre-
term birth rate less than 37 weeks for women with a sin-
gleton pregnancy is 6.3% versus 97% for women with a
triplet pregnancy [1] the mean gestational age of birth for
infants of a triplet pregnancy being 31.9 weeks, with
39.3% if infants born before 32 weeks gestation, and a fur-
ther 57.7% between 32 and 36 weeks gestation [1].
Infants of a triplet pregnancy are at increased risk of poor
intrauterine growth, with the mean birth weight of a tri-
plet infant being 1668 grams, compared 3398 with grams
in singleton infants [1]. At birth, 15.9% of triplet infants
weigh less than 1000 grams, 35.9% less than 1500 grams,
and 92.9% less than 2500 grams [1]. Infants of a higher
order multiple pregnancy are at increased risk of perinatal
death, with a rate of 53.0/1000, almost 7 times greater
than that observed in singletons [1].
Several studies have demonstrated a favourable effect of
bed rest for women with a triplet pregnancy on fetal
growth [2,3]. However, advice regarding the timing and
duration of bed rest has varied, including hospitalisation
from 28 to 30 weeks gestation until birth [4], from 24
weeks until the beginning of the third trimester [5], or
only at the onset of complications [6].
Hospital admission has been advocated in the past for
women with a twin pregnancy, as a means of reducing the
risk of preterm birth and improving fetal growth [7].
However, the Cochrane Systematic Review assessing the
role of hospitalisation and bed rest for women with an
uncomplicated twin pregnancy has found the practice to
be associated with an increase in the risk of preterm birth,
and should not be offered as part of routine care [8].
The value of admission to hospital for rest in triplet or
higher order multiple pregnancy is uncertain, with little
consistent information available. Several retrospective
studies assessing bed rest for women with a triplet preg-
nancy suggest a reduction in the risk of preterm birth
[9,10], while others have not demonstrated a prolonga-
tion in gestation [4,11]. The effect of bed rest on perinatal
mortality is similarly associated with inconsistent find-
ings, some authors reporting a reduction in mortality
[4,9,10], others not [11].
In the only small, randomised study to date in 19 triplet
pregnancies, hospitalisation for rest suggests a beneficial
trend in reducing the incidence of preterm birth and of
increased birthweight in the hospitalised group [12]. All
of these beneficial results are compatible with chance var-
iation. There is a need for further evaluation of the effects
of admission to hospital for rest in women with a triplet
pregnancy.
Any potentially beneficial effects of hospitalisation and
bed rest for infant health outcomes must be considered in
light of the physical and psychosocial effects on the preg-
nant woman [13,14]. The separation from family mem-
bers and the practical issues related to this separation have
been identified as a considerable stressor associated with
hospitalisation [13].
This randomised controlled trial was designed to assess
the effects of hospitalisation from 24 to 30 weeks gesta-
tion for women with a triplet pregnancy on the risk of pre-
term birth. Our primary hypotheses were that routine
hospitalisation of women with a triplet pregnancy from
24 to 30 weeks gestation would be associated with a
reduction in the incidence of preterm birth (defined as
birth less than 37 weeks), and very preterm birth (defined
as birth less than 34 weeks).
Methods
Women with a triplet pregnancy, with ultrasound con-
firmed gestational age of less than 24 weeks were
approached from the antenatal clinic of the Women's and
Children's Hospital for participation in the study. Women
with a triplet pregnancy and any other condition requir-
ing hospitalisation (for example, placenta praevia) were
excluded from participation in the trial. Approval was
obtained from the research and ethics committee of the
Women's and Children's Hospital. Recruitment com-
menced in 1996 and was terminated 2003 due to a lack of
success in securing research funding to support multicen-
tred collaboration, and difficulties experienced in recruit-
ing sufficient women.
Women with a triplet pregnancy were identified early in
their antenatal care, provided with the trial information,
and asked to discuss their participation with a family
member. Women who provided informed written con-
sent were then randomised to either antenatal hospitalisa-
tion (hospitalised group), or to routine antenatal care
(control group). The randomisation schedule used varia-
ble blocks with stratification by parity, and was prepared
by an investigator not involved in clinical care. After com-
pletion of the trial entry details, an independent
researcher responsible for treatment allocation was con-
tacted by telephone, and the next in a series of consecu-
tively numbered, opaque, sealed envelopes opened. The
treatment allocation was stated over the telephone for
either hospitalisation for bed rest (hospitalised group) or
not (control group) according to the instructions enclosed
in the envelope.BMC Pregnancy and Childbirth 2005, 5:8 http://www.biomedcentral.com/1471-2393/5/8
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Women allocated to the hospitalised group were admitted
to hospital from 24 weeks gestation until 30 weeks gesta-
tion, after which time, women were discharged home and
encouraged to obtain as much rest as possible. All women
were able to ambulate within the hospital, received a nor-
mal hospital diet, and fortnightly routine antenatal assess-
ments. Women were allowed leave from the ward over
weekend periods to assist with compliance with contin-
ued hospitalisation.
Women allocated to the control group were encouraged to
continue with their normal activities at home, and were
reviewed fortnightly in the antenatal clinic. They were
admitted to hospital if any complications developed, such
as preterm labour, preterm prelabour ruptured mem-
branes, and pregnancy induced hypertension.
Baseline characteristic were obtained to describe the two
groups at randomisation, and included maternal age,
booking weight and height, smoking and alcohol use,
mode of conception (spontaneous conception versus con-
ception via assisted reproductive techniques), previous
pregnancy outcomes, and use of antenatal corticosteroids
for fetal lung maturation. The primary study outcomes
were the incidence of preterm birth (defined as birth less
than 37 weeks gestation) and very preterm birth (defined
as birth less than 34 weeks gestation), and the develop-
ment of maternal pregnancy induced hypertension
(defined as blood pressure greater than 140/90 mmHg or
an increase in the diastolic blood pressure of more than
15 mmHg from booking. Secondary outcome measures
included tocolytic use, mode of birth, infant Apgar score
of less than seven at five minutes, infant birth weight less
than 2500 grams, infant birth weight less than 1500
grams, admission to the neonatal unit, length of stay in
the neonatal unit more than seven days, perinatal death
(stillbirth and neonatal death), and the occurrence of neo-
natal morbidity (including respiratory distress syndrome,
intraventricular haemorrhage, and necrotising
enterocolitis).
The previous randomised controlled trial assessing hospi-
talisation and bed rest for women with a triplet pregnancy
suggests a reduction in the occurrence of preterm birth
less than 34 weeks gestation from 44% to 30% [12]. A
sample of 400 women would be able to detect this differ-
ence, at a level of statistical significance of 5%, and power
of 80%. Using preterm birth less than 37 weeks gestation,
a sample of 52 women would be able to detect a reduction
from 100% to 80% (p = 0.05; power = 80%).
Baseline characteristics were compared, to assess compa-
rability of the treatment groups at trial entry. All ran-
domised women were included in the analysis on an
intention to treat basis. Relative risks and 95% confidence
intervals were calculated for primary and secondary out-
comes. These results were then incorporated into a sys-
tematic review and meta-analysis with the previous trial of
hospitalisation and bed rest for women with a triplet preg-
nancy [12].
Results
Seven women with a triplet pregnancy at less that 24
weeks gestation were recruited to the trial, with three
women randomised to the hospitalisation group, and
four women to the control group. Baseline characteristics
between the two groups were comparable (Table 1).
Of the women in the hospitalisation group, two devel-
oped antenatal complications (one pregnancy induced
hypertension, and one recurrent antepartum haemor-
rhage), two gave birth by caesarean section (both prela-
bour procedures), and two developed postnatal
complications (one primary postpartum haemorrhage,
and one raised blood pressure). All three women were
administered antenatal corticosteroids, but none were
Table 1: Baseline antenatal characteristics
Characteristic Hospitalisation Group N = 3 Control Group N = 4
Gestational age at randomisation (weeks)* 23.4 ± 1.7 22.0 ± 1.8
Maternal Age (years)* 33.2 ± 0.8 36.2 ± 13.2
Booking Weight (kg)* 62.3 ± 11.0 61.3 ± 3.2
Height (cm)* 170.0 ± 1.5 164.5 ± 3.5
Caucasian 3 4
Married / Defacto 3 4
Primigravid 2 2
Smoker 1 0
Alcohol use in pregnancy 1 0
Conception spontaneous 1 2
*mean and standard deviationBMC Pregnancy and Childbirth 2005, 5:8 http://www.biomedcentral.com/1471-2393/5/8
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administered antenatal tocolytic agents. All three women
gave birth at less than 37 weeks gestation, and two at less
than 34 weeks gestation (Table 2).
Of the women in the control group, three were admitted
during their antenatal course (one for threatened preterm
labour, one for pregnancy induced hypertension, and one
for recurrent antepartum haemorrhage and one for intra-
uterine growth restriction), three of the four women were
administered antenatal corticosteroids and one woman
received antenatal tocolytic agents. All four women gave
birth by caesarean section (three elective prelabour proce-
dures), and three developed postnatal complications (one
postpartum haemorrhage and two raised blood pressure).
All four women gave birth at less than 37 weeks gestation,
and two women gave birth at less than 34 weeks gestation.
There were no statistically significant differences between
the two groups for any of the infant outcomes (Table 3).
There were no stillbirths and two neonatal deaths in one
triplet grouping in the control group (one due to tracheal
Table 2: Primary outcome measures
Outcome Hospitalisation Group N = 3 Control Group N = 4 Relative Risk 95% CI
Birth <37 weeks gestation 3 4 Not estimable
Birth <34 weeks gestation 3 2 2.00 0.75 to 5.33
Pregnancy induced hypertension 1 1 1.33 0.13 to 13.74
Figures are numbers
Table 3: Secondary outcome measures
Outcome Hospitalisation Group N = 9 Control Group N = 12 Relative Risk 95% CI
Gestational age at birth 
(weeks)*
33.5 ± 2.7 33.5 ± 3.5 -0.01 -4.60 to 4.53
Birth weight (grams)* 1892 ± 251.8 1810 ± 551.8 82.00 -314.28 to 478.28
Birth weight <2500 grams 9 8 1.12 0.89 to 1.42
Birth weight <1500 grams 1 3 0.33 0.04 to 2.63
Placental weight (grams)* 906.7 ± 136.5 1210.5 ± 557.9 -303.83 -1082.18 to 474.52
Apgar score <7 at 5 mins 0 1 0.33 0.04 to 2.63
Neonatal Death 0 2 0.20 0.01 to 3.66
Neonatal Morbidity 0 1 0.33 0.02 to 7.24
Figures are numbers and relative risk or *mean and standard deviation, and weighted mean difference
Table 4: Meta-analysis of two randomised trials assessing bed rest for triplets
Outcome Number Trials Number Participants Relative Risk 95% Confidence Intervals
Gestational age at birth (weeks)* 2 26 0.57 -1.36 to 2.51
Birth <37 weeks gestation 2 26 0.80 0.59 to 1.09
Birth <34 weeks gestation 2 26 0.87 0.36 to 2.08
Caesarean section 2 26 1.18 0.47 to 2.96
Maternal hypertension 2 26 0.43 0.11 to 1.72
Birth weight <2500 grams 2 75 0.87 0.36 to 2.08
Birth weight <1500 grams 2 75 1.18 0.47 to 2.96
Apgar score <7 at 5 mins 2 75 0.43 0.11 to 1.72
Neonatal unit admission 2 71 0.90 0.74 to 1.09
Neonatal stay >7 days 2 71 1.39 0.80 to 2.42
Perinatal Death 2 78 2.71 0.12 to 63.84
Neonatal Death 2 75 0.19 0.02 to 1.53
*weighted mean differenceBMC Pregnancy and Childbirth 2005, 5:8 http://www.biomedcentral.com/1471-2393/5/8
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stenosis and the other to necrotising enterocolitis and
bowel infarction).
When the results of this trial are incorporated into a meta-
analysis with the previous randomised controlled trial
assessing hospitalisation and bed rest for women with a
triplet pregnancy [12], a total sample size of 26 women
and 78 infants is obtained. There were no statistically sig-
nificant differences identified between the two groups for
the outcomes reported (Table 4).
Discussion
The results of this small randomised trial and meta-analy-
sis suggest no benefit of routine hospitalisation and bed
rest for women with a triplet pregnancy in reducing the
risk of preterm birth and improving fetal growth. The
effect of the additional seven women recruited from this
trial has been to reduce the magnitude of potential bene-
ficial trends identified previously [12], with the point esti-
mates for outcomes coming closer to unity. While the
combined sample size in the meta-analysis of 26 women
remains underpowered to be able to reliably detect differ-
ences in rates of preterm birth and in particular, perinatal
mortality, it is unlikely that there will be further attempts
to answer the question of the value of hospitalisation and
bed rest in women with triplet pregnancies in the form of
randomised controlled trials. In any case, the reduction in
magnitude of potential benefits somewhat reduces the
degree of uncertainty that remains in clinical practice.
The difficulties encountered in recruitment to this trial
highlight a number of issues. Randomised trials where the
target population (in this case, women with a triplet preg-
nancy) comprise a small proportion of the obstetric pop-
ulation will, by necessity, require multicentred
collaboration. While this trial received ethics approval
from a number of collaborating centres, all women
recruited were from the coordinating centre. This may
reflect an inability of busy clinicians to actively recruit
women due to time constraints within their practice, or
lack of specific funding, thereby relying on collaborators
to act altruistically, with little financial or other rewards
for multicentre collaboration [15]. While the current
health care system may not be conducive to active partic-
ipation in clinical research, it is unlikely that the structure
will change sufficiently in the short term. Another equally
difficult approach may be to change the attitude of obste-
tricians, with greater emphasis, particularly during train-
ing, on the need for research. If clinical research is then
viewed as a "normal" component of clinical practice, par-
ticipation and recruitment to clinical trials may be facili-
tated [15]. After all, in the face of uncertainty about a
clinical intervention or treatment, the most ethical
response on the part of the clinician is to offer participa-
tion in a clinical trial [16], which essentially involves
"choice under uncertainty, plus data collection" [17].
Conclusion
The results of this trial and meta-analysis suggest no ben-
efit of routine hospitalisation and bed rest for women
with a triplet pregnancy in terms of reducing the risk of
preterm birth and improving fetal growth. The adoption
or continuation of a policy of routine hospitalisation and
bed rest for women with an uncomplicated triplet preg-
nancy cannot be recommended.
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